Overview

A Phase Ⅱ Study of XELOX Chemotherapy With or Without Surgery of Primary Lesion for Colon Cancer Patients

Status:
Unknown status
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
The primary endpoint is to evaluate the TFS (time to failure of strategy).
Phase:
Phase 2
Details
Lead Sponsor:
Fudan University
Treatments:
Capecitabine
Oxaliplatin